Condensed IP

Randy Noranbrock
  • 5.0 (1)
  • Entrepreneurship

An AI-generated, human-curated podcast for brief discussions of US court decisions on Intellectual Property topics.

  1. 2d ago

    Ollnova Technologies Ltd. v. ecobee Technologies (Fed. Cir., June 4, 2026) 2025-1045

    This episode concerns a judicial opinion from the Federal Circuit addressing a patent dispute between Ollnova Technologies and ecobee regarding wireless building automation systems. The court vacated the infringement and damages judgments, ordering a new trial because the lower court improperly grouped multiple patents into a single verdict question, which risked a non-unanimous decision. Additionally, the court found the jury instructions for the '495 patent flawed for failing to identify the specific abstract idea being analyzed under federal patent eligibility standards. While the court remanded the '495 patent for further proceedings, it upheld the validity of the '887 and '371 patents, ruling they provided specific technological solutions rather than mere abstract concepts. Finally, the appellate judges affirmed that ecobee was not entitled to a judgment of non-infringement on the '371 patent, as sufficient evidence supported the original jury findings. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    23 min

  2. Jun 10

    Hikma Pharmaceuticals v Amarin Pharma (U.S., June 4, 2026) 2024-889

    This episode concerns the case of Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the Supreme Court addressed whether a generic drug manufacturer can be held liable for active inducement of patent infringement through its marketing and labeling. Amarin alleged that Hikma's "skinny label" and promotional materials encouraged doctors to prescribe its generic drug for a still-patented cardiovascular use, even though the label was only approved for a non-patented indication. The Court unanimously ruled in favor of Hikma, clarifying that active inducement requires affirmative and purposeful steps to promote infringement rather than passive omissions or vague statements. Justice Jackson emphasized that the legal standard for a motion to dismiss requires a plaintiff to show more than a mere possibility that a physician might misunderstand a generic’s intended use. Consequently, the Court found that standard industry practices, such as describing a product as a generic equivalent or citing total market sales, do not constitute illegal encouragement. This decision provides significant protection for generic manufacturers using section viii "carve-outs" to bring cheaper medications to market without facing speculative litigation. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    17 min

  3. Jun 7

    AGI SureTrack v. Farmers Edge (Fed. Cir., June 2, 2026) 2024-1730

    This episode concerns a judicial opinion from the United States Court of Appeals for the Federal Circuit regarding a patent dispute between AGI SureTrack LLC and Farmers Edge Inc. The court affirmed a lower court's ruling that AGI’s patents were ineligible because they were directed toward the abstract idea of collecting and analyzing farming data using generic technology. While AGI argued their system solved technical interoperability issues, the judges found the claims lacked an inventive concept necessary to transform them into a patentable application. Conversely, the court vacated the decision that the case was not exceptional, ordering a remand to reconsider whether Farmers Edge is entitled to attorney's fees. This remand allows for a deeper review of alleged misconduct and litigation tactics that the district court initially dismissed without a detailed explanation. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    13 min

  4. Jun 5

    Insulet v. EOFlow (Fed. Cir., May 28, 2026) 2025-1807

    This episode concerns the case of Insulet Corp. v. EOFlow at the United States Court of Appeals for the Federal Circuit. The Federal Circuit reversed a massive jury award regarding trade secret misappropriation involving wearable insulin pumps. The court determined it had jurisdiction because related patent claims were effectively dismissed with prejudice due to the statute of limitations. On the merits, the majority concluded that Insulet’s claims were time-barred because the company should have discovered the alleged theft more than three years before filing suit. Evidence showed that Insulet was aware of former employees joining its competitor and had observed striking physical similarities between the rival products at trade shows years earlier. A dissenting opinion argued that the court overstepped by overturning the jury’s factual findings and applied a standard that encourages premature litigation. Ultimately, the reversal nullifies the damages and permanent injunction previously granted against EOFlow. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    18 min

  5. Jun 4

    Versata v. Ford (Fed. Cir., May 22, 2026) 2024-1140

    This episode concerns an opinion from the United States Court of Appeals for the Federal Circuit detailing a dispute between Versata Software and Ford Motor Company regarding trade secret misappropriation and breach of contract. The court affirmed Ford’s liability for stealing software trade secrets but vacated a lower court's ruling that had reduced Versata's damages to zero. The judges determined that Versata has a statutory right to pursue unjust enrichment damages, rather than being restricted only to a model based on past licensing fees. Additionally, the appellate court reinstated an $82.2 million jury award for breach of contract, finding the original calculation was supported by sufficient evidence. The case has been remanded for a new trial specifically to determine the appropriate financial compensation for the trade secret claims. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    21 min

  6. May 31

    A.L.M. Holding Co. v. Zydex Industries (Fed. Cir., May 19, 2026) 2025-1317

    This episode concerns a legal opinion from the United States Court of Appeals for the Federal Circuit addressing whether a patent owner retains Article III standing after granting an exclusive license to another party. The case involves A.L.M. Holding Company and Ergon Asphalt, who appealed a lower court's dismissal of their infringement suit against Zydex Industries. The appellate court reversed the dismissal, determining that the plaintiffs kept sufficient exclusionary rights to satisfy constitutional requirements. Specifically, the court found that the plaintiffs' retained right to sue, their royalty interests, and their veto power over sublicensing ensured their legal interests were not illusory. By distinguishing this case from prior precedents, the judges clarified that a patent owner does not need to possess all substantial rights to maintain the standing necessary to pursue a lawsuit in federal court. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    16 min

  7. May 21

    mCom IP, LLC v. City National Bank of Florida (Fed. Cir., May 15, 2026) 2024-2089

    This episode concerns an opinion from the United States Court of Appeals for the Federal Circuit detailing a patent infringement dispute between mCom IP, LLC and City National Bank of Florida. The court affirmed the dismissal of mCom's lawsuit, agreeing with the lower court that the asserted claims regarding electronic banking systems were invalid due to obviousness. However, the appellate court reversed the financial sanctions and attorney fees previously awarded against mCom and its counsel. The judges determined that the case did not meet the "exceptional" threshold for such penalties, as there was no evidence of bad faith or frivolous litigation. Ultimately, while mCom lost its claim on the merits of the patent, the court protected the company and its lawyer from punitive legal costs. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    18 min

  8. May 18

    Actelion Pharmaceuticals v. Mylan Pharmaceuticals (Fed. Cir., May 13, 2026) 2024-1641

    In this episode, the United States Court of Appeals for the Federal Circuit affirmed that Mylan Pharmaceuticals Inc.did not infringe upon patents held by Actelion Pharmaceuticals Ltd. regarding the hypertension drug Veletri®. The legal dispute centered on the requirement that the drug be manufactured from a "bulk solution" with a pH of 13 or higher, a threshold Actelion claimed was met by Mylan’s refrigerated process. However, the court determined that the term "pH" refers to measurements taken at a standard temperature of 25°C, a condition Mylan's product did not satisfy. Furthermore, the court rejected Actelion’s attempt to claim infringement through the doctrine of equivalents, ruling that the company had previously narrowed its claims during prosecution and dedicated certain pH ranges to the public. This decision reinforces industry standards by requiring precise temperature conditions for pH-related patent claims unless otherwise specified. This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

    15 min
See All (108)

Ratings & Reviews

About

An AI-generated, human-curated podcast for brief discussions of US court decisions on Intellectual Property topics.

Information

  • Creator
    Randy Noranbrock
  • Years Active
    2025 - 2026
  • Episodes
    108
  • Rating
    Clean
  • Copyright
    © 2026 Condensed IP
  • Show Website
    Condensed IP